Neoadjuvant Sintilimab Combined with Gemcitabine and Cisplatin for Muscle-Invasive Bladder Cancer Patients Followed by Selective Bladder Sparing Surgery: A Phase 2 Trial.
Saved in:
| Title: | Neoadjuvant Sintilimab Combined with Gemcitabine and Cisplatin for Muscle-Invasive Bladder Cancer Patients Followed by Selective Bladder Sparing Surgery: A Phase 2 Trial. |
|---|---|
| Authors: | Tong, Zhou1 (AUTHOR), Fu, Guanghou2 (AUTHOR), Zhou, Feng2 (AUTHOR), Liu, Xiaoyan3 (AUTHOR), Xue, Xing4 (AUTHOR), Zhang, Hangyu1 (AUTHOR), Wang, Yimin2 (AUTHOR), Zhu, Xudong1 (AUTHOR), Gao, Yang1 (AUTHOR), Liu, Lulu1 (AUTHOR), Bao, Xuanwen1 (AUTHOR), Zheng, Yi1 (AUTHOR), Fang, Weijia1 (AUTHOR), Zhao, Peng1 (AUTHOR) zhaop@zju.edu.cn, Jin, Baiye2 (AUTHOR) jinbaiye1964@zju.edu.cn |
| Source: | Cancer Research & Treatment. Apr2026, Vol. 58 Issue 2, p581-590. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15982998 |
|---|---|
| DOI: | 10.4143/crt.2025.214 |
